| # | Drug | Count |
|---|---|---|
| 0 | LENALIDOMIDE | 18 |
| 1 | DEXAMETHASONE | 16 |
| 2 | DEXAMETHASONE 1.5 MG | 16 |
| 3 | CARFILZOMIB | 15 |
| 4 | FLUTICASONE FUROATE | 14 |
| 5 | FUROSEMIDE | 14 |
| 6 | IRBESARTAN | 14 |
| 7 | ISATUXIMAB | 14 |
| 8 | ZOLEDRONIC ACID | 14 |
| 9 | RASBURICASE | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RASBURICASE | 13 | 0.0053 |
| 1 | ISATUXIMAB | 14 | 0.0024 |
| 2 | TOLNAFTATE | 1 | 0.0008 |
| 3 | EPCORITAMAB-BYSP | 1 | 0.0007 |
| 4 | CARFILZOMIB | 15 | 0.0005 |
| 5 | ZOLEDRONIC ACID | 14 | 0.0003 |
| 6 | IRBESARTAN | 14 | 0.0003 |
| 7 | RAMUCIRUMAB | 1 | 0.0002 |
| 8 | AVACOPAN | 1 | 0.0001 |
| 9 | FLUCONAZOLE | 10 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 20 |
| 1 | Thalidomide Analog [EPC] | 19 |
| 2 | Proteasome Inhibitor [EPC] | 15 |
| 3 | Angiotensin 2 Receptor Blocker [EPC] | 14 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 14 |
| 5 | Loop Diuretic [EPC] | 14 |
| 6 | Azole Antifungal [EPC] | 11 |
| 7 | Opioid Agonist [EPC] | 11 |
| 8 | Interleukin-6 Receptor Antagonist [EPC] | 10 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 14 | 0.0024 |
| 1 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 2 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 3 | Complement 5a Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | Proteasome Inhibitor [EPC] | 15 | 0.0001 |
| 5 | Antimalarial [EPC] | 1 | 0.0001 |
| 6 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 7 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 8 | Interleukin-6 Receptor Antagonist [EPC] | 10 | 0.0001 |
| 9 | Azole Antifungal [EPC] | 11 | 0.0001 |